IQ-AI Ltd - London-based medical services company - Amends existing distribution agreement with artificial intelligence platform provider Blackford Analysis Ltd. The amendment adds IB Nimble, IB ASL, IB FTB, and IB FTB Express to the agreement, allowing Blackford to also sell these products to their global client base. Acquired by Bayer in early 2023, Blackford operates in the healthcare AI platform and solutions sphere.
Current stock price: 1.66 pence
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2025 Alliance News Ltd. All Rights Reserved.


IQ-AI Ltd - London-based medical services company - Says subsidiary Imaging Biometrics LLC has applied for breakthrough therapy designation from the U...


IQ-AI Ltd - London-based medical services company - Provides operations update focusing on artificial intelligence. Explains radiology leads the way i...


IQ-AI Ltd - parent of Wisconsin-based Imaging Biometrics LLC, which provides quantitative imaging platforms and therapeutics for the diagnosis and tre...


UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination


IN BRIEF: IQ-AI Says Development Of Stroke Diagnostic Product On Track


IN BRIEF: IQ-AI Starts Development Of Cancer Detection Product


UK Shareholder Meetings Calendar - Next 7 Days


UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks


IQ-AI Shares Fall As Annual Loss Widens Despite Revenue Growth


IQ-AI Secures StoneChecker Software Approval In South Korea


IQ-AI Signs Distribution Agreement For Liver Analysis Technology